This study is looking at whether a digital support tool can help people with Postpartum Depression or Mental and Behavioural Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Poland
Why is this study shown?
This study is directly about Depression.
Depression, BipolarityDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United Kingdom
Why is this study shown?
This study is directly about Depression.
DepressionDrug
Countries
United Kingdom
Sponsor
Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company, Ltd
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Germany
Why is this study shown?
This study is directly about Depression.
DepressionDrug
Countries
Germany
Sponsor
Medizinische Fakultät. Otto von Guericke Universität
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United Kingdom
Why is this study shown?
This study is directly about Depression.
DepressionDrug
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
This study was withdrawn in the United States. It is testing Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy for treatment-resistant depression.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.